Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Bioheart Announces Plans to Advance LVAD + Muscle Stem Cells Clinical Trial

December 8, 2010 By Bio-Medicine.Org

SUNRISE, Fla., Dec. 8, 2010 /PRNewswire-FirstCall/ — Bioheart,
Inc. (OTC Bulletin Board:
BHRT) announced today that at the American Heart Association
Annual Meeting, it finalized the formation of a working group. The
group’s focus is to advance a BRIDGE TO RECOVERY clinical trial,
combining a left ventricle assist device (LVAD) and Bioheart’s
MyoCell adult muscle stem cell composition and Bioheart’s MyoCath
needle tipped catheter delivery system.   Initial participants
in developing this proposed protocol design include:Dr. Frank
Pagani, University of MichiganDr. Warren Sherman, Columbia
UniversityDr. Ernst Schwarz, Ceders Sinai UCLADr. Nabil Dib,
University of California San Diego and Mercy Gilbert Hospital
PhoenixDr. Carl Pepine, University of Florida Shands HospitalDr.
Doris Taylor, University of MinnesotaThe expected study design
pending potential modification will include 3 treatment arms:
Group 1 – Patients receive MyoCell SDF-1 single dose via MyoCath
catheter delivery after LVAD placement.Group 2 – Patients receive
MyoCell in multiple injection sessions over 6 months via MyoCath
catheter delivery following LVAD placement.Group 3 – Patients
receive LVAD only. The end points in the trial will include
exercise capacity, functional improvements and success in weaning
off the LVAD.”At the AHA meeting, improvements in survival of heart
failure patients were reported from trials with battery powered
pacers and mechanical left ventricle assist heart pumps.
 These devices help patients cope with their failing heart,
but do little to repair damaged scar tissue in the heart, which is
often the primary source of heart failure.  The MyoCell
composition from Bioheart has demonstrated an ability to grow new
contractile muscle in scar tissue and thus, may actually address
the underlying problem.  Supporting the patient with an LVAD
temporarily during the time period

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech